These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1605 related articles for article (PubMed ID: 33523115)

  • 1. Association of Intravenous Immunoglobulins Plus Methylprednisolone vs Immunoglobulins Alone With Course of Fever in Multisystem Inflammatory Syndrome in Children.
    Ouldali N; Toubiana J; Antona D; Javouhey E; Madhi F; Lorrot M; Léger PL; Galeotti C; Claude C; Wiedemann A; Lachaume N; Ovaert C; Dumortier M; Kahn JE; Mandelcwajg A; Percheron L; Biot B; Bordet J; Girardin ML; Yang DD; Grimaud M; Oualha M; Allali S; Bajolle F; Beyler C; Meinzer U; Levy M; Paulet AM; Levy C; Cohen R; Belot A; Angoulvant F;
    JAMA; 2021 Mar; 325(9):855-864. PubMed ID: 33523115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
    Son MBF; Murray N; Friedman K; Young CC; Newhams MM; Feldstein LR; Loftis LL; Tarquinio KM; Singh AR; Heidemann SM; Soma VL; Riggs BJ; Fitzgerald JC; Kong M; Doymaz S; Giuliano JS; Keenaghan MA; Hume JR; Hobbs CV; Schuster JE; Clouser KN; Hall MW; Smith LS; Horwitz SM; Schwartz SP; Irby K; Bradford TT; Maddux AB; Babbitt CJ; Rowan CM; McLaughlin GE; Yager PH; Maamari M; Mack EH; Carroll CL; Montgomery VL; Halasa NB; Cvijanovich NZ; Coates BM; Rose CE; Newburger JW; Patel MM; Randolph AG;
    N Engl J Med; 2021 Jul; 385(1):23-34. PubMed ID: 34133855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Multisystem Inflammatory Syndrome in Children.
    McArdle AJ; Vito O; Patel H; Seaby EG; Shah P; Wilson C; Broderick C; Nijman R; Tremoulet AH; Munblit D; Ulloa-Gutierrez R; Carter MJ; De T; Hoggart C; Whittaker E; Herberg JA; Kaforou M; Cunnington AJ; Levin M;
    N Engl J Med; 2021 Jul; 385(1):11-22. PubMed ID: 34133854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparative analysis of factors affecting the decision and outcome of initial intravenous immunoglobulin alone or intravenous immunoglobulin plus methylprednisolone use in children with the multisystem inflammatory syndrome.
    Devrim İ; Böncüoğlu E; Kıymet E; Şahinkaya Ş; Çelebi MY; Cem E; Düzgöl M; Arıkan KÖ; Kara AA; Besin D; Vuran G; Seven P; Meşe T; Ağın H; Bayram N
    Pediatr Rheumatol Online J; 2022 Aug; 20(1):69. PubMed ID: 35987681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
    Villacis-Nunez DS; Jones K; Jabbar A; Fan L; Moore W; Peter AS; Henderson M; Xiang Y; Kelleman MS; Sherry W; Chandrakasan S; Oster ME; Jaggi P; Prahalad S
    JAMA Pediatr; 2022 Jun; 176(6):576-584. PubMed ID: 35344042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Experience: Corticosteroids as a First-line Therapy in Children With Multisystem Inflammatory Syndrome and COVID-19-related Myocardial Damage.
    Vukomanovic V; Krasic S; Prijic S; Ninic S; Popovic S; Petrovic G; Ristic S; Simic R; Cerovic I; Nesic D
    Pediatr Infect Dis J; 2021 Nov; 40(11):e390-e394. PubMed ID: 34260481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
    Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
    Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    Feldstein LR; Tenforde MW; Friedman KG; Newhams M; Rose EB; Dapul H; Soma VL; Maddux AB; Mourani PM; Bowens C; Maamari M; Hall MW; Riggs BJ; Giuliano JS; Singh AR; Li S; Kong M; Schuster JE; McLaughlin GE; Schwartz SP; Walker TC; Loftis LL; Hobbs CV; Halasa NB; Doymaz S; Babbitt CJ; Hume JR; Gertz SJ; Irby K; Clouser KN; Cvijanovich NZ; Bradford TT; Smith LS; Heidemann SM; Zackai SP; Wellnitz K; Nofziger RA; Horwitz SM; Carroll RW; Rowan CM; Tarquinio KM; Mack EH; Fitzgerald JC; Coates BM; Jackson AM; Young CC; Son MBF; Patel MM; Newburger JW; Randolph AG;
    JAMA; 2021 Mar; 325(11):1074-1087. PubMed ID: 33625505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet Child Adolesc Health; 2024 Mar; 8(3):190-200. PubMed ID: 38272046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome.
    Pereira MFB; Litvinov N; Farhat SCL; Eisencraft AP; Gibelli MABC; Carvalho WB; Fernandes VR; Fink TT; Framil JVS; Galleti KV; Fante AL; Fonseca MFM; Watanabe A; Paula CSY; Palandri GG; Leal GN; Diniz MFR; Pinho JRR; Silva CA; Marques HHS; ; Rossi Junior A; Delgado AF; Andrade APM; Schvartsman C; Sabino EC; Rocha MC; Kanunfre KA; Okay TS; Carneiro-Sampaio MMS; Jorge PPD
    Clinics (Sao Paulo); 2020; 75():e2209. PubMed ID: 32844958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory Therapy for MIS-C.
    Ouldali N; Son MBF; McArdle AJ; Vito O; Vaugon E; Belot A; Leblanc C; Murray NL; Patel MM; Levin M; Randolph AG; Angoulvant F;
    Pediatrics; 2023 Jul; 152(1):. PubMed ID: 37376963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Profile and Short-Term Outcome of Children With SARS-CoV-2 Related Multisystem Inflammatory Syndrome (MIS-C) Treated With Pulse Methylprednisolone.
    Sugunan S; Bindusha S; Geetha S; Niyas HR; Kumar AS
    Indian Pediatr; 2021 Aug; 58(8):718-722. PubMed ID: 33876782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 11 cases multisystem inflammatory syndrome associated with SARS-CoV-2 Omicron variant infection in children].
    Zhang HS; Chang XT; Wu PH; Song DY; Ge G; Ding W; Hu ZW; Wang GF; Jiang YW; Ye LP
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):55-59. PubMed ID: 38154978
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial Immunomodulation and Outcome of Children with Multisystem Inflammatory Syndrome Related to COVID-19: A Multisite Study from India.
    Bagri NK; Khan M; Pandey RM; Lodha R; Kabra SK;
    Indian J Pediatr; 2022 Dec; 89(12):1236-1242. PubMed ID: 35699843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review.
    Wang Z; Zhao S; Tang Y; Wang Z; Shi Q; Dang X; Gan L; Peng S; Li W; Zhou Q; Li Q; Mafiana JJ; Cortés RG; Luo Z; Liu E; Chen Y
    Eur J Pediatr; 2022 May; 181(5):2135-2146. PubMed ID: 35192051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIS-C Treatment: Is glucocorticoid monotherapy enough for mild cases?
    Sütçü M; Kara EM; Yıldız F; Gül D; Yıldız R; Yılmaz D; Atik F; Özkaya O
    Am J Emerg Med; 2024 Sep; 83():95-100. PubMed ID: 39002497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center.
    Sözeri B; Çağlayan Ş; Atasayan V; Ulu K; Coşkuner T; Pelin Akbay Ö; Hasbal Akkuş C; Atay G; Salı E; Karacan M; Öner T; Erdoğan S; Demir F
    Postgrad Med; 2021 Nov; 133(8):994-1000. PubMed ID: 34605352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.
    Tagarro A; Domínguez-Rodríguez S; Mesa JM; Epalza C; Grasa C; Iglesias-Bouzas MI; Fernández-Cooke E; Calvo C; Villaverde S; Torres-Fernández D; Méndez-Echevarria A; Leoz I; Fernández-Pascual M; Saavedra-Lozano J; Soto B; Aguilera-Alonso D; Rivière JG; Fumadó V; Martínez-Campos L; Vivanco A; Pilar-Orive FJ; Alcalá P; Ruiz B; López-Machín A; Oltra M; Moraleda C;
    Eur J Pediatr; 2023 Jan; 182(1):461-466. PubMed ID: 36282324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Multi-inflammatory Syndrome in Children Temporally Related to COVID 19-Clinical Course, Laboratory Profile and Outcomes from a North Indian PICU.
    Chattopadhyay A; Saigal Kalra K; Saikia D; Yadav V; Chouksey J; Jajoo M; Sherwal BL
    J Intensive Care Med; 2022 Sep; 37(9):1229-1237. PubMed ID: 35469487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 81.